Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member
tabling member	label

Search

1503851

	registered interest
	date	02/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Monkeypox: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many doses of monkeypox vaccine have been delivered to NHS patients (a) in the last 12 months and (b) since May 2022.
	tabling member constituency	Ilford North
	tabling member printed	Wes Streeting
	uin	45437
	answer	answer is ministerial correction date of answer 20/09/2022 answer text <p>As of 30 August 2022, a total of 38,079 administered doses of vaccine have been recorded in England, of which 33,918 doses have been administered as pre-exposure vaccination, primarily to gay and bisexual people and other men who have sex with men. A further 1,992 doses have been provided to healthcare workers managing monkeypox cases and 2,169 doses have been given to close contacts of cases.</p><p>No smallpox vaccines were issued for the purposes of monkeypox response between September 2021 and May 2022.</p> answering member constituency Sleaford and North Hykeham answering member printed Dr Caroline Johnson question first answered 20/09/2022 14:33:32 answering member 4592 label Biography information for Dr Caroline Johnson previous answer version 17710 answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey answering member 4098
	tabling member	4504 label Biography information for Wes Streeting

1504906

	registered interest
	date	05/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sickle Cell Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans he has to (a) increase awareness of Sickle Cell disease and (b) improve the training for dealing with that disease among (i) nurses and doctors in training and (ii) practising NHS nurses and doctors.
	tabling member constituency	East Ham
	tabling member printed	Sir Stephen Timms
	uin	47331
	answer	answer is ministerial correction date of answer 20/09/2022 answer text <p>As part of this years’ World Sickle Cell Day, NHS England launched a new sickle cell disease awareness campaign on the signs and symptoms of sickle cell disease, aimed at urgent and emergency care staff and those living with the condition and their carers.</p><p>There have been recent improvements to the haematology medical curriculum, with understanding sickle cell disease and thalassemia now described in the curriculum as core competencies. Health Education England (HEE) provides e-learning which includes content on sickle cell disease. HEE has held discussions with the Royal Colleges of Pathology and Physicians to ensure this curriculum is deliverable to all four nations, in line with General Medical Council’s (GMC) standards. The Haemoglobinopathy Coordinating Centres also provide network development, leadership, learning and education.</p><p>The Sickle Cell Society and the All-Party Parliamentary Group on Sickle Cell and Thalassaemia report ‘No One’s Listening’ highlighted the lack of awareness of sickle cell disease among healthcare professionals. Officials are considering the report’s recommendations. NHS England estimates that awareness amongst accident and emergency medical and nursing staff, specifically of conditions such as sickle cell disease, is high across England and in areas where there is a higher prevalence of the condition. However, NHS England and other bodies continue with further awareness raising.</p><p>No specific assessment has been made regarding the extent of compliance to the National Institute for Health and Care Excellence’s (NICE) guidance on pain relief for sickle cell patients. The Care Quality Commission (CQC) considers evidence of how registered persons have met fundamental standards through its regulatory approach. The CQC will consider the processes providers have to ensure that best practice is implemented for quality standards, including NICE’s guidelines.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 47332 47333 question first answered 20/09/2022 14:27:53 answering member 4423 label Biography information for Will Quince previous answer version 17713 answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey answering member 4098
	tabling member	163 label Biography information for Sir Stephen Timms

1504908

	registered interest
	date	05/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sickle Cell Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the level of awareness among NHS ambulance and A and E staff of the need for urgency in dealing with a Sickle Cell crisis.
	tabling member constituency	East Ham
	tabling member printed	Sir Stephen Timms
	uin	47332
	answer	answer is ministerial correction date of answer 20/09/2022 answer text <p>As part of this years’ World Sickle Cell Day, NHS England launched a new sickle cell disease awareness campaign on the signs and symptoms of sickle cell disease, aimed at urgent and emergency care staff and those living with the condition and their carers.</p><p>There have been recent improvements to the haematology medical curriculum, with understanding sickle cell disease and thalassemia now described in the curriculum as core competencies. Health Education England (HEE) provides e-learning which includes content on sickle cell disease. HEE has held discussions with the Royal Colleges of Pathology and Physicians to ensure this curriculum is deliverable to all four nations, in line with General Medical Council’s (GMC) standards. The Haemoglobinopathy Coordinating Centres also provide network development, leadership, learning and education.</p><p>The Sickle Cell Society and the All-Party Parliamentary Group on Sickle Cell and Thalassaemia report ‘No One’s Listening’ highlighted the lack of awareness of sickle cell disease among healthcare professionals. Officials are considering the report’s recommendations. NHS England estimates that awareness amongst accident and emergency medical and nursing staff, specifically of conditions such as sickle cell disease, is high across England and in areas where there is a higher prevalence of the condition. However, NHS England and other bodies continue with further awareness raising.</p><p>No specific assessment has been made regarding the extent of compliance to the National Institute for Health and Care Excellence’s (NICE) guidance on pain relief for sickle cell patients. The Care Quality Commission (CQC) considers evidence of how registered persons have met fundamental standards through its regulatory approach. The CQC will consider the processes providers have to ensure that best practice is implemented for quality standards, including NICE’s guidelines.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 47331 47333 question first answered 20/09/2022 14:27:53 answering member 4423 label Biography information for Will Quince previous answer version 17714 answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey answering member 4098
	tabling member	163 label Biography information for Sir Stephen Timms

1504909

	registered interest
	date	05/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sickle Cell Diseases: Analgesics
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the extent of compliance in the NHS with NICE guidance that Sickle Cell patients should receive pain relief within 30 minutes of admittance to Accident and Emergency care; and if he will make a statement.
	tabling member constituency	East Ham
	tabling member printed	Sir Stephen Timms
	uin	47333
	answer	answer is ministerial correction date of answer 20/09/2022 answer text <p>As part of this years’ World Sickle Cell Day, NHS England launched a new sickle cell disease awareness campaign on the signs and symptoms of sickle cell disease, aimed at urgent and emergency care staff and those living with the condition and their carers.</p><p>There have been recent improvements to the haematology medical curriculum, with understanding sickle cell disease and thalassemia now described in the curriculum as core competencies. Health Education England (HEE) provides e-learning which includes content on sickle cell disease. HEE has held discussions with the Royal Colleges of Pathology and Physicians to ensure this curriculum is deliverable to all four nations, in line with General Medical Council’s (GMC) standards. The Haemoglobinopathy Coordinating Centres also provide network development, leadership, learning and education.</p><p>The Sickle Cell Society and the All-Party Parliamentary Group on Sickle Cell and Thalassaemia report ‘No One’s Listening’ highlighted the lack of awareness of sickle cell disease among healthcare professionals. Officials are considering the report’s recommendations. NHS England estimates that awareness amongst accident and emergency medical and nursing staff, specifically of conditions such as sickle cell disease, is high across England and in areas where there is a higher prevalence of the condition. However, NHS England and other bodies continue with further awareness raising.</p><p>No specific assessment has been made regarding the extent of compliance to the National Institute for Health and Care Excellence’s (NICE) guidance on pain relief for sickle cell patients. The Care Quality Commission (CQC) considers evidence of how registered persons have met fundamental standards through its regulatory approach. The CQC will consider the processes providers have to ensure that best practice is implemented for quality standards, including NICE’s guidelines.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 47331 47332 question first answered 20/09/2022 14:27:53 answering member 4423 label Biography information for Will Quince previous answer version 17715 answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey answering member 4098
	tabling member	163 label Biography information for Sir Stephen Timms

1504900

	registered interest
	date	05/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Care Workers: Allowances
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if his Department will offer support to local authorities to help social care providers to increase the mileage allowance paid to care workers.
	tabling member constituency	Stockport
	tabling member printed	Navendu Mishra
	uin	47691
	answer	answer is ministerial correction date of answer 20/09/2022 answer text <p>Under the Care Act 2014, local authorities have a duty to manage local care markets. The vast majority of care workers are employed by private sector providers which set their terms and conditions, including renumeration for travel costs, independently of Government. Local authorities work with care providers to determine fee rates, which should take account of employment costs, based on local market conditions.</p><p>We are committing £1.36 billion to the Market Sustainability and Fair Cost of Care Fund. The Fund will support local authorities to prepare markets for reform and move towards paying providers a fair cost of care. The Government continues to work with local government and care providers to understand the impact from challenges such as energy price rises and inflationary pressures.</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 20/09/2022 14:35:49 answering member 4679 label Biography information for Neil O'Brien previous answer version 17725 answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey answering member 4098
	tabling member	4811 label Biography information for Navendu Mishra

1505163

	registered interest
	date	05/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Evusheld
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when he expects NICE's review of Evusheld to be concluded.
	tabling member constituency	North Durham
	tabling member printed	Mr Kevan Jones
	uin	47379
	answer	answer is ministerial correction date of answer 20/09/2022 answer text <p>On 10 August 2022, the Department referred tixagevimab and cilgavimab (Evusheld) to the National Institute for Health and Care Excellence (NICE) to evaluate its clinical and cost effectiveness for preventing COVID-19. Between 29 July and 12 August, NICE consulted with stakeholders on the suggested remit, draft scope and list of consultees and commentators.</p><p>NICE has commenced this evaluation and currently expects to publish draft guidance in April 2023, with final guidance to follow in May 2023. In discussion with AstraZeneca, NICE is expediting the appraisal process by bringing forward the deadline for the manufacturer’s evidence submission.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 20/09/2022 14:34:16 answering member 4320 label Biography information for Robert Jenrick previous answer version 17716 answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey answering member 4098
	tabling member	1438 label Biography information for Mr Kevan Jones

1505139

	registered interest
	date	05/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Nurses: Recruitment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when he expects eligible post-graduate nurses to receive the £10,000 golden hello payment announced in May 2018.
	tabling member constituency	Kingston upon Hull East
	tabling member printed	Karl Turner
	uin	47512
	answer	answer is ministerial correction date of answer 20/09/2022 answer text <p>In May 2018, we announced the intention to pay a ‘golden hello’ to nurses who started a postgraduate course in learning disability nursing, mental health nursing or district nursing in the 2018/19 academic year who subsequently qualified and were employed in these roles in the health and care sector.</p><p>The Government is considering the most effective way to administer and introduce any scheme to ensure it delivers on the original intent.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 20/09/2022 14:37:11 answering member 4320 label Biography information for Robert Jenrick previous answer version 17720 answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey answering member 4098
	tabling member	4030 label Biography information for Karl Turner

1504776

	registered interest
	date	05/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Temporary Employment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the total cost to NHS hospitals was of using (a) agency and (b) bank staff in each region in England in the 2021-22 financial year.
	tabling member constituency	Enfield North
	tabling member printed	Feryal Clark
	uin	47698
	answer	answer is ministerial correction date of answer 20/09/2022 answer text <p>The information requested is not yet held in the format requested as the accounts for 2021/22 are currently being audited.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 20/09/2022 14:35:04 answering member 4320 label Biography information for Robert Jenrick previous answer version 17726 answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey answering member 4098
	tabling member	4822 label Biography information for Feryal Clark

1504891

	registered interest
	date	05/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Respiratory Syncytial Virus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, on what date he expects NHS England’s Palivizumab Expert Group to respond to the request from the JCVI to consider the eligibility of children with spinal muscular atrophy to receive the Palivizumab vaccination against respiratory syncytial virus.
	tabling member constituency	St Albans
	tabling member printed	Daisy Cooper
	uin	47662
	answer	answer is ministerial correction date of answer 20/09/2022 answer text <p>Respiratory syncytial virus (RSV) infection poses a serious risk for children with spinal muscular atrophy (SMA) with weakened respiratory muscles due to their condition. Following a letter from clinicians, the Joint Committee on Vaccination and Immunisation (JCVI) has requested that NHS England’s Palivizumab National Expert Group consider the eligibility of a sub-group of children with SMA to receive palivizumab vaccination this winter. This Group is preparing a briefing and on completion, it will meet and report the outcome of its discussion and recommendations to the JCVI. A specific date has yet to be confirmed.</p> answering member constituency Sleaford and North Hykeham answering member printed Dr Caroline Johnson grouped question UIN 47663 question first answered 20/09/2022 14:29:09 answering member 4592 label Biography information for Dr Caroline Johnson previous answer version 17723 answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey answering member 4098
	tabling member	4769 label Biography information for Daisy Cooper

1504892

	registered interest
	date	05/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Respiratory Syncytial Virus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to recommendations in the consensus statement of the 2017 International Conference on the Standards of Care on the use of Palivizumab for some categories of children with spinal muscular atrophy to protect from respiratory syncytial virus, if he will take steps to urgently review the eligibility criteria for the Palivizumab vaccine.
	tabling member constituency	St Albans
	tabling member printed	Daisy Cooper
	uin	47663
	answer	answer is ministerial correction date of answer 20/09/2022 answer text <p>Respiratory syncytial virus (RSV) infection poses a serious risk for children with spinal muscular atrophy (SMA) with weakened respiratory muscles due to their condition. Following a letter from clinicians, the Joint Committee on Vaccination and Immunisation (JCVI) has requested that NHS England’s Palivizumab National Expert Group consider the eligibility of a sub-group of children with SMA to receive palivizumab vaccination this winter. This Group is preparing a briefing and on completion, it will meet and report the outcome of its discussion and recommendations to the JCVI. A specific date has yet to be confirmed.</p> answering member constituency Sleaford and North Hykeham answering member printed Dr Caroline Johnson grouped question UIN 47662 question first answered 20/09/2022 14:29:09 answering member 4592 label Biography information for Dr Caroline Johnson previous answer version 17724 answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey answering member 4098
	tabling member	4769 label Biography information for Daisy Cooper